These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34413525)

  • 1. Bifunctional small molecules that mediate the degradation of extracellular proteins.
    Caianiello DF; Zhang M; Ray JD; Howell RA; Swartzel JC; Branham EMJ; Chirkin E; Sabbasani VR; Gong AZ; McDonald DM; Muthusamy V; Spiegel DA
    Nat Chem Biol; 2021 Sep; 17(9):947-953. PubMed ID: 34413525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capacity limits of asialoglycoprotein receptor-mediated liver targeting.
    Bon C; Hofer T; Bousquet-Mélou A; Davies MR; Krippendorff BF
    MAbs; 2017; 9(8):1360-1369. PubMed ID: 28876162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapies on the horizon: Targeted protein degradation in neuroscience.
    Gregory JA; Hickey CM; Chavez J; Cacace AM
    Cell Chem Biol; 2024 Sep; 31(9):1688-1698. PubMed ID: 39303702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of novel mono- and bivalent ASGP-R-targeted drug-conjugates.
    Petrov RA; Maklakova SY; Ivanenkov YA; Petrov SA; Sergeeva OV; Yamansarov EY; Saltykova IV; Kireev II; Alieva IB; Deyneka EV; Sofronova AA; Aladinskaia AV; Trofimenko AV; Yamidanov RS; Kovalev SV; Kotelianski VE; Zatsepin TS; Beloglazkina EK; Majouga AG
    Bioorg Med Chem Lett; 2018 Feb; 28(3):382-387. PubMed ID: 29269214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASGPR-Mediated Uptake of Multivalent Glycoconjugates for Drug Delivery in Hepatocytes.
    Monestier M; Charbonnier P; Gateau C; Cuillel M; Robert F; Lebrun C; Mintz E; Renaudet O; Delangle P
    Chembiochem; 2016 Apr; 17(7):590-4. PubMed ID: 26781030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Triantennary N-Acetylgalactosamine Conjugates as Degraders for Extracellular Proteins.
    Zhou Y; Teng P; Montgomery NT; Li X; Tang W
    ACS Cent Sci; 2021 Mar; 7(3):499-506. PubMed ID: 33791431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of cereblon-dependent targeted protein degrader by visualizing the spatiotemporal ternary complex formation in cells.
    Kaji T; Koga H; Kuroha M; Akimoto T; Hayata K
    Sci Rep; 2020 Feb; 10(1):3088. PubMed ID: 32080280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the first small molecule histone deacetylase 6 (HDAC6) degraders.
    Yang K; Song Y; Xie H; Wu H; Wu YT; Leisten ED; Tang W
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2493-2497. PubMed ID: 29871848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of carbohydrate-functionalized cyclodextrins and liposomes for hepatocyte-specific targeting.
    Bernardes GJ; Kikkeri R; Maglinao M; Laurino P; Collot M; Hong SY; Lepenies B; Seeberger PH
    Org Biomol Chem; 2010 Nov; 8(21):4987-96. PubMed ID: 20820666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kukoamine B promotes TLR4-independent lipopolysaccharide uptake in murine hepatocytes.
    Yang D; Zheng X; Wang N; Fan S; Yang Y; Lu Y; Chen Q; Liu X; Zheng J
    Oncotarget; 2016 Sep; 7(36):57498-57513. PubMed ID: 27542278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted protein degradation and the enzymology of degraders.
    Fisher SL; Phillips AJ
    Curr Opin Chem Biol; 2018 Jun; 44():47-55. PubMed ID: 29885948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential of Proteolytic Chimeras as Pharmacological Tools and Therapeutic Agents.
    Coll-Martínez B; Delgado A; Crosas B
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33339292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of a Triantennary Quinoline Glycoconjugate with the Asialoglycoprotein Receptor.
    Palit S; Banerjee S; Mahata T; Niyogi S; Das T; Sova Mandi C; Chakrabarti P; Dutta S
    ChemMedChem; 2021 Jul; 16(14):2211-2216. PubMed ID: 33860988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrochemical evidence for asialoglycoprotein receptor--mediated hepatocyte adhesion and proliferation in three dimensional tissue engineering scaffolds.
    Vasanthan KS; Sethuraman S; Parthasarathy M
    Anal Chim Acta; 2015 Aug; 890():83-90. PubMed ID: 26347169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma.
    Petrov RA; Mefedova SR; Yamansarov EY; Maklakova SY; Grishin DA; Lopatukhina EV; Burenina OY; Lopukhov AV; Kovalev SV; Timchenko YV; Ondar EE; Ivanenkov YA; Evteev SA; Vaneev AN; Timoshenko RV; Klyachko NL; Erofeev AS; Gorelkin PV; Beloglazkina EK; Majouga AG
    Mol Pharm; 2021 Jan; 18(1):461-468. PubMed ID: 33264010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications.
    D'Souza AA; Devarajan PV
    J Control Release; 2015 Apr; 203():126-39. PubMed ID: 25701309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation.
    Ahn G; Banik SM; Miller CL; Riley NM; Cochran JR; Bertozzi CR
    Nat Chem Biol; 2021 Sep; 17(9):937-946. PubMed ID: 33767387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin and asialoglyprotein receptor mediate hepatitis B surface antigen binding to the cell surface.
    Yang J; Wang F; Tian L; Su J; Zhu X; Lin L; Ding X; Wang X; Wang S
    Arch Virol; 2010 Jun; 155(6):881-8. PubMed ID: 20364278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular glue-mediated targeted protein degradation: A novel strategy in small-molecule drug development.
    Tan X; Huang Z; Pei H; Jia Z; Zheng J
    iScience; 2024 Sep; 27(9):110712. PubMed ID: 39297173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery.
    Pathak PO; Nagarsenker MS; Barhate CR; Padhye SG; Dhawan VV; Bhattacharyya D; Viswanathan CL; Steiniger F; Fahr A
    Carbohydr Res; 2015 May; 408():33-43. PubMed ID: 25841057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.